ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
Oral BPC-157 For Potential Gut Health
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="BadassBlues" data-source="post: 271789" data-attributes="member: 38526"><p>[URL unfurl="true"]https://pubmed.ncbi.nlm.nih.gov/27847966/[/URL]</p><p></p><h3><em>Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation</em></h3><p><em><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Hsieh+MJ&cauthor_id=27847966" target="_blank">Ming-Jer Hsieh</a> <a href="https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-1" target="_blank">1</a> <a href="https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-2" target="_blank">2</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Liu+HT&cauthor_id=27847966" target="_blank">Hsien-Ta Liu</a> <a href="https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-1" target="_blank">1</a> <a href="https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-3" target="_blank">3</a> <a href="https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-4" target="_blank">4</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wang+CN&cauthor_id=27847966" target="_blank">Chao-Nin Wang</a> <a href="https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-5" target="_blank">5</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Huang+HY&cauthor_id=27847966" target="_blank">Hsiu-Yun Huang</a> <a href="https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-1" target="_blank">1</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Lin+Y&cauthor_id=27847966" target="_blank">Yuling Lin</a> <a href="https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-1" target="_blank">1</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ko+YS&cauthor_id=27847966" target="_blank">Yu-Shien Ko</a> <a href="https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-2" target="_blank">2</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Wang+JS&cauthor_id=27847966" target="_blank">Jong-Shyan Wang</a> <a href="https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-6" target="_blank">6</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Chang+VH&cauthor_id=27847966" target="_blank">Vincent Hung-Shu Chang</a> <a href="https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-7" target="_blank">7</a>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=Pang+JS&cauthor_id=27847966" target="_blank">Jong-Hwei S Pang</a> <a href="https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-8" target="_blank">8</a> <a href="https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-9" target="_blank">9</a></em></p><p><em>Affiliations expand</em></p><ul> <li data-xf-list-type="ul"><em><em>PMID: <strong>27847966</strong></em></em></li> <li data-xf-list-type="ul"><em><em>DOI: <a href="https://doi.org/10.1007/s00109-016-1488-y" target="_blank">10.1007/s00109-016-1488-y</a></em></em></li> </ul><h3><em>Abstract</em></h3><p><em>BPC 157, a pentadecapeptide with extensive healing effects, has recently been suggested to contribute to angiogenesis. However, the underlying mechanism is not yet clear. The present study aimed to explore the potential therapeutic effect and pro-angiogenic mechanism of BPC 157. As demonstrated by the chick chorioallantoic membrane (CAM) assay and endothelial tube formation assay, BPC 157 could increase the vessel density both in vivo and in vitro, respectively. BPC 157 could also accelerate the recovery of blood flow in the ischemic muscle of the rat hind limb as detected by laser Doppler scanning, indicating the promotion of angiogenesis. Histological analysis of the hind limb muscle confirmed the increased number of vessels and the enhanced vascular expression of vascular endothelial growth factor receptor 2 (VEGFR2) in rat with BPC 157 treatment.<strong> In vitro study using human vascular endothelial cells further confirmed the increased mRNA and protein expressions of VEGFR2 but not VEGF-A by BPC 157. </strong>In addition, BPC 157 could promote VEGFR2 internalization in vascular endothelial cells which was blocked in the presence of dynasore, an inhibitor of endocytosis. BPC 157 time dependently activated the VEGFR2-Akt-eNOS signaling pathway which could also be suppressed by dynasore. The increase of endothelial tube formation induced by BPC 157 was also inhibited by dynasore. This study demonstrates the pro-angiogenic effects of BPC 157 that is associated with the increased expression, internalization of VEGFR2, and the activation of VEGFR2-Akt-eNOS signaling pathway. BPC 157 promotes angiogenesis in CAM assay and tube formation assay. BPC 157 accelerates the blood flow recovery and vessel number in rats with hind limb ischemia. BPC 157 up-regulates VEGFR2 expression in rats with hind limb ischemia and endothelial cell culture. BPC 157 promotes VEGFR2 internalization in association with VEGFR2-Akt-eNOS activation.</em></p><p><em><strong>Key message: </strong>BPC 157 promotes angiogenesis in CAM assay and tube formation assay. BPC 157 accelerates the blood flow recovery and vessel number in rats with hind limb ischemia. BPC 157 up-regulates VEGFR2 expression in rats with hind limb ischemia and endothelial cell culture. BPC 157 promotes VEGFR2 internalization in association with VEGFR2-Akt-eNOS activation.</em></p></blockquote><p></p>
[QUOTE="BadassBlues, post: 271789, member: 38526"] [URL unfurl="true"]https://pubmed.ncbi.nlm.nih.gov/27847966/[/URL] [HEADING=2][I]Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation[/I][/HEADING] [I][URL='https://pubmed.ncbi.nlm.nih.gov/?term=Hsieh+MJ&cauthor_id=27847966']Ming-Jer Hsieh[/URL] [URL='https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-1']1[/URL] [URL='https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-2']2[/URL], [URL='https://pubmed.ncbi.nlm.nih.gov/?term=Liu+HT&cauthor_id=27847966']Hsien-Ta Liu[/URL] [URL='https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-1']1[/URL] [URL='https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-3']3[/URL] [URL='https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-4']4[/URL], [URL='https://pubmed.ncbi.nlm.nih.gov/?term=Wang+CN&cauthor_id=27847966']Chao-Nin Wang[/URL] [URL='https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-5']5[/URL], [URL='https://pubmed.ncbi.nlm.nih.gov/?term=Huang+HY&cauthor_id=27847966']Hsiu-Yun Huang[/URL] [URL='https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-1']1[/URL], [URL='https://pubmed.ncbi.nlm.nih.gov/?term=Lin+Y&cauthor_id=27847966']Yuling Lin[/URL] [URL='https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-1']1[/URL], [URL='https://pubmed.ncbi.nlm.nih.gov/?term=Ko+YS&cauthor_id=27847966']Yu-Shien Ko[/URL] [URL='https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-2']2[/URL], [URL='https://pubmed.ncbi.nlm.nih.gov/?term=Wang+JS&cauthor_id=27847966']Jong-Shyan Wang[/URL] [URL='https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-6']6[/URL], [URL='https://pubmed.ncbi.nlm.nih.gov/?term=Chang+VH&cauthor_id=27847966']Vincent Hung-Shu Chang[/URL] [URL='https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-7']7[/URL], [URL='https://pubmed.ncbi.nlm.nih.gov/?term=Pang+JS&cauthor_id=27847966']Jong-Hwei S Pang[/URL] [URL='https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-8']8[/URL] [URL='https://pubmed.ncbi.nlm.nih.gov/27847966/#full-view-affiliation-9']9[/URL] Affiliations expand[/I] [LIST] [*][I][I]PMID: [B]27847966[/B][/I][/I] [*][I][I]DOI: [URL='https://doi.org/10.1007/s00109-016-1488-y']10.1007/s00109-016-1488-y[/URL][/I][/I] [/LIST] [HEADING=2][I]Abstract[/I][/HEADING] [I]BPC 157, a pentadecapeptide with extensive healing effects, has recently been suggested to contribute to angiogenesis. However, the underlying mechanism is not yet clear. The present study aimed to explore the potential therapeutic effect and pro-angiogenic mechanism of BPC 157. As demonstrated by the chick chorioallantoic membrane (CAM) assay and endothelial tube formation assay, BPC 157 could increase the vessel density both in vivo and in vitro, respectively. BPC 157 could also accelerate the recovery of blood flow in the ischemic muscle of the rat hind limb as detected by laser Doppler scanning, indicating the promotion of angiogenesis. Histological analysis of the hind limb muscle confirmed the increased number of vessels and the enhanced vascular expression of vascular endothelial growth factor receptor 2 (VEGFR2) in rat with BPC 157 treatment.[B] In vitro study using human vascular endothelial cells further confirmed the increased mRNA and protein expressions of VEGFR2 but not VEGF-A by BPC 157. [/B]In addition, BPC 157 could promote VEGFR2 internalization in vascular endothelial cells which was blocked in the presence of dynasore, an inhibitor of endocytosis. BPC 157 time dependently activated the VEGFR2-Akt-eNOS signaling pathway which could also be suppressed by dynasore. The increase of endothelial tube formation induced by BPC 157 was also inhibited by dynasore. This study demonstrates the pro-angiogenic effects of BPC 157 that is associated with the increased expression, internalization of VEGFR2, and the activation of VEGFR2-Akt-eNOS signaling pathway. BPC 157 promotes angiogenesis in CAM assay and tube formation assay. BPC 157 accelerates the blood flow recovery and vessel number in rats with hind limb ischemia. BPC 157 up-regulates VEGFR2 expression in rats with hind limb ischemia and endothelial cell culture. BPC 157 promotes VEGFR2 internalization in association with VEGFR2-Akt-eNOS activation. [B]Key message: [/B]BPC 157 promotes angiogenesis in CAM assay and tube formation assay. BPC 157 accelerates the blood flow recovery and vessel number in rats with hind limb ischemia. BPC 157 up-regulates VEGFR2 expression in rats with hind limb ischemia and endothelial cell culture. BPC 157 promotes VEGFR2 internalization in association with VEGFR2-Akt-eNOS activation.[/I] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Peptide Forums (GHRH, Sermorelin, etc)
General Peptide Use & Information
Oral BPC-157 For Potential Gut Health
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top